Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.

[1]  H. Griffiths.  Osteoporosis: Physiological Basis, Assessment and Treatment , 1990 .

[2]  Kenneth G. Mann,et al.  Evidence of estrogen receptors in normal human osteoblast-like cells , 1988 .

[3]  B. Komm,et al.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. , 1988, Science.

[4]  J. Gallagher,et al.  Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin. , 1988, The Journal of reproductive medicine.

[5]  J. Gallagher,et al.  Total bone calcium in normal women: Effect of age and menopause status , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  L. Weinstein.  Efficacy of a Continuous Estrogen‐Progestin Regimen in the Menopausal Patient , 1987, Obstetrics and gynecology.

[7]  C. Christiansen,et al.  The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. , 1987, American journal of obstetrics and gynecology.

[8]  H. Genant,et al.  Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. , 1987, Annals of internal medicine.

[9]  Roger A. Renfrew,et al.  Lipid Research Clinics Program. , 1984, JAMA.

[10]  R. Lindsay,et al.  The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss , 1984, Obstetrics and gynecology.

[11]  H. Genant,et al.  Spinal mineral loss in oophorectomized women. Determination by quantitative computed tomography. , 1980, JAMA.

[12]  C. Christiansen,et al.  Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females , 1971, European journal of clinical investigation.

[13]  G. Heiss,et al.  Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia. , 1980, Journal of chronic diseases.

[14]  L. Nachtigall,et al.  Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis. , 1979 .

[15]  S. Manolagas,et al.  Detection of high-affinity glucocorticoid binding in rat bone. , 1978, The Journal of endocrinology.

[16]  R. Lindsay,et al.  Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. , 1978, Clinical science and molecular medicine.

[17]  R. Recker,et al.  Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. , 1977, Annals of internal medicine.

[18]  A. Horsman,et al.  Prospective trial of oestrogen and calcium in postmenopausal women. , 1977, British medical journal.

[19]  D. Feldman,et al.  Glucocorticoid receptors and inhibition of bone cell growth in primary culture. , 1977, Endocrinology.

[20]  R. Lindsay,et al.  LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN EVIDENCE FOR AN INCREASED BONE MASS AFTER DELAYED ONSET OF ŒSTROGEN TREATMENT , 1976, The Lancet.

[21]  J. Gallagher,et al.  Effects of oestrogen and progestogen therapy on calcium metabolism in post-menopausal women. , 1975, Frontiers of hormone research.

[22]  R. Lindsay,et al.  Oestrogen Replacement Therapy for Prevention of Osteoporosis after Oophorectomy , 1973, British medical journal.